Tellgen Corporation (SHE:300642)

Market Cap	2.41B +13.7%
Revenue (ttm)	371.54M -11.2%
Net Income	-2.44M
EPS	-0.02
Shares Out	159.86M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.10 (0.64%)
Ex-Dividend Date	May 20, 2025

Volume	2,448,180
Average Volume	3,308,627
Open	15.62
Previous Close	15.55
Day's Range	15.10 - 15.73
52-Week Range	13.60 - 32.80
Beta	0.41
RSI	33.08
Earnings Date	Apr 25, 2026

About Tellgen

Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; tumor methylation; cardiovascular, eugenics, and inflammation. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in 2003 and is based in Shanghai, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 522
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300642

Financial Performance

In 2025, Tellgen's revenue was 363.83 million, a decrease of -16.70% compared to the previous year's 436.78 million. Earnings were 3.59 million, a decrease of -89.61%.